Methotrimeprazine is a phenothiazine antipsychotic agent used to treat schizophrenia, manic-depressive syndromes, and other severe psychotic disorders by blocking dopamine receptors in the central nervous… Read more
Methotrimeprazine is a phenothiazine antipsychotic agent used to treat schizophrenia, manic-depressive syndromes, and other severe psychotic disorders by blocking dopamine receptors in the central nervous system. This category includes high-quality reference standards of the active pharmaceutical ingredient, alongside its degradation products and metabolites. Laboratories require these compounds for precise impurity profiling, method validation, and routine quality control during drug development and stability testing. By utilizing stable isotope labelled compounds, such as methotrimeprazine-d6 and -d3 hydrochloride, researchers can perform accurate quantitative analysis, serving as internal standards in mass spectrometry to account for matrix effects and variations in recovery. These reference materials are critical for ensuring regulatory compliance and consistency when assessing the purity and metabolic pathways of phenothiazine formulations in various analytical applications.